REFERENCES
- Enck RE. Mucosal membranes as alternative routes for morphine sulfate administration. Am J Hosp Care 1988; 5:17–18.
- Pitorak EF, Kraus JC. Pain control with sublingual morphine. The advantages for hospice care. Am J Hosp Care 1987; 4:39–41.
- Pannuti F, Rossi AP, Iafelice G, Marraro D, Camera P, Cricca A, Strocchi E, Burroni P, Lapucci L, Fruet F. Control of chronic pain in very advanced cancer patients with morphine hydrochloride administered by oral, rectal and sublingual route. Clinical report and preliminary results on morphine pharmacokinetics. Pharmacol Res Commum 1982; 14:369–380.
- Hirsh JD. Sublingual morphine sulfate in chronic pain management. Clin Pharm 1984; 3:585–586.
- Whitman HH. Sublingual morphine. A novel route of narcotic administration. Am J Nurs 1984; 84:939.
- Shephard KV, Bakst AW. Alternative delivery methods for morphine sulfate in cancer pain. Cleve Clin J Med 1990; 57:48–52.
- Fisher AP, Fung C, Hanna M. Serum morphine concentration after buccal and intramuscular morphine administration. Br J Clin Pharmacol 1987; 24:685–687.
- Al-Sayed-Omar O, Johnston A, Turner P. Influence of pH on the buccal absorption of morphine sulfate and its major metabolite, morphine-3-glucuronide. J Pharm Pharmacol 1987; 39:934–935.
- Osborne R, Joel S, Trew D, Slevin M. Morphine and metabolite behavior after different routes of morphine administration: demonstration of the importance of the active metabolite morphine-6-glucuronide. Clin Pharmacol Ther 1990; 47:12–19.
- Weinberg DS, Inturrisi CE, Reidenberg B, Moulin DF, Nip TJ, Wallenstein S, Houde RW, Foley KM. Sublingual absorption of selected opioid analgesics. Clin Pharmacol Ther 1988; 44:335–342.
- Gracely RH. Psychophysical assessment of human pain. Adv Pain Res Therapy 1979; 3:805–824.
- Grabinski PY, Kaiko RF, Walsh TD, Foley KM, Honde RW. Morphine radioimmunoassay specificity before and after extraction of plasma and cerebrospinal fluid. J Pharm Sci 1983; 72:27–29.